Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Cosmetic Formulation
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Dupilumab, cendakimab, and IL-13 targeting in EoE: patent landscape, key assignees, and emerging biologic pipeline strategies analysed by PatSnap.
Article | Rapport Patent intelligence across carbon, pseudocapacitive, and hybrid supercapacitor electrode materials — mapping who owns the IP, where white space exists, and what's emerging in 2026.
Article | Rapport Thread milling vs. tapping for aerospace titanium: patent-backed analysis of tool breakage risk, chip evacuation, residual stress, and precision thread forming trade-offs.
Article | Rapport Explore the MDS drug pipeline: imetelstat, luspatercept-class agents, and hypomethylating agent combinations. Patent-driven intelligence on targets, biomarkers, and assignees.
Article | Rapport Explore the 2026 PV inverter technology landscape: AI diagnostics, digital twins, VPP integration, and MPPT evolution across 80+ patent records.
Article | Rapport How digital twins, PLC monitoring, and physical signal overlays form CPS security architecture for critical manufacturing. Patent intelligence from 30+ global filings.
Article | Rapport Explore the MDS drug pipeline: imetelstat, luspatercept-class agents, and HMA combination strategies reshaping myelodysplastic syndrome treatment. Patent intelligence analysis.
Article | Rapport Analyse 70+ patents spanning 2014–2026 to map the lidar-camera sensor fusion landscape: key assignees, calibration IP battles, and emerging NeRF-based fusion paradigms.
Article | Rapport How digital twins, PLC monitoring, and honeypot architectures define CPS security for critical manufacturing. Patent intelligence analysis from 30+ filings.
Article | Rapport Explore the 2026 passive radiative cooling patent landscape: metamaterial emitters, photonic stacks, daytime PV integration, and emerging power-generation applications.
Article | Rapport How tarlatamab (AMG 757) and the DLL3-targeting bispecific pipeline are reshaping treatment for extensive-stage small cell lung cancer. Patent signals, clinical data, and strategic analysis.
Article | Rapport How patent-backed strategies — from solid-state storage to MIMO control — cut balance-of-plant complexity in offshore wind-powered hydrogen production.
Article | Rapport A 2026 patent landscape of passive radiative cooling: four material clusters, 8+ jurisdictions, and emerging bifunctional cooling-plus-power devices. Explore the IP signals.
Article | Rapport How engineers and patent holders are simplifying balance-of-plant complexity in offshore wind-powered hydrogen production — from solid-state storage to MIMO control.
Article | Rapport PI3K inhibitors, bispecific antibodies, and ADCs are reshaping follicular lymphoma treatment. Explore the patent landscape, key assignees, and emerging combination strategies.